StockData
ProKidney Corp. logo

ProKidney Corp. (PROK) income statement

PROKNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 5/30
$1.04−0.02 (-1.89%)

Close on Nov 20, 2026Market cap $314.42MP/E –Yield –

See a number that looks wrong?